spacer
home > advertise
ADVERTISING OPPORTUNITIES
Why Advertise with Samedan?

 

Samedan's range of specialist titles spans the full spectrum of pharmaceutical development, from innovation to patient, and is designed to meet the broad
needs of an industry built on high-quality information, communication, and expertise.

With a history going back more than a decade, Samedan's clients range from long-established industry leaders to the most recent start-ups and university spin-outs.
Many clients have advertised across our entire range for years and have come to
appreciate a strong and cooperative relationship with us.

Samedan is committed to providing the perfect editorial platform for your advert.
That is why our featured articles take an opinion-led, non-promotional view of the industry. This ensures that every advert enjoys maximum impact with each title's readership of 10,000+ key decision makers.

For further information about each of our titles, follow the links below. Each of our advertising executives can be contacted at the email addresses below and will be
pleased to discuss how Samedan can meet your needs.

Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747

European Pharmaceutical Contractor
George Briggs: george@samedanltd.com 

European BioPharmaceutical Review
Sam Bromley:  sam@samedanltd.com 

International Clinical Trials
George Briggs: george@samedanltd.com 

Pharmaceutical Manufacturing and Packing Sourcer
Simon Caplan: simon@samedanltd.com

Innovations in Pharmaceutical Technology
Sam Bromley:  sam@samedanltd.com 



spacer

Industry Events

ESMO Targeted Anticancer Therapies Congress 2020

2-4 March 2020, Paris, France

A unique and international mix of experts, researchers and decision makers both from academia and industry across the globe, will convene in Paris for a three-day Congress aiming at exchanging knowledge, experience and research innovations in cancer. TAT 2020 will focus, among others, on novel strategies in immuno-oncology, personalised medicine and molecular tumour boards, preclinical studies to identify effective combination therapies, use of microbiome, tumour agnostic trials, ADC technology, oncolytics, multispecific biological constructs and targeting cytokines. Participating in TAT 2020 will offer you the possibility to take part in interdisciplinary discussions inspiring new ideas and new collaborations.
More info >>

News and Press Releases

Merck Launches ADC ExpressTM Services to Accelerate Pre-clinical Conjugation Candidate Selection

Provides rapid production of antibody drug conjugates (ADCs) for best candidate selection Established platform technology to reliably scale target molecules Reduces time to clinic through comprehensive ADC services from pre-clinical to commercial from a single source
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement